Telomir Pharmaceuticals Ownership | Who Owns Telomir Pharmaceuticals?


OverviewRevenueFinancialsChart

Telomir Pharmaceuticals Ownership Summary


Telomir Pharmaceuticals is owned by 6.34% institutional investors, 44.98% insiders, and 48.68% retail investors. Vanguard group is the largest institutional shareholder, holding 3.67% of TELO shares.

TELO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockTelomir Pharmaceuticals6.34%44.98%48.68%
SectorHealthcare Stocks 42.50%10.81%46.69%
IndustryBiotech Stocks 45.24%10.75%44.01%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group1.10M3.67%$1.53M
Blackrock funding, inc. /de291.43K0.97%$405.09K
Geode capital management196.03K0.65%$272.63K
Raymond james financial75.34K0.25%$104.72K
Ubs group63.54K0.21%$88.31K
State street58.60K0.20%$81.45K
Bank of new york mellon51.45K0.17%$71.52K
Suncoast equity management51.19K0.17%$71.16K
Northern trust41.84K0.14%$58.16K
Advisor group24.51K0.08%$32.50K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Suncoast equity management51.19K0.01%$71.16K
Praetorian wealth management20.00K0.01%$27.80K
Resources investment advisors, llc.23.00K0.00%$31.97K
Clearstead advisors12.53K0.00%$17.42M
Kestra private wealth services11.00K0.00%$15.29K
Tower research capital llc (trc)1.25K-$1.74K
Cwm---
Marshall wace, llp---
Eversource wealth advisors379.00-$527.00
New york state common retirement fund---

Top Buyers

HolderShares% AssetsChange
Raymond james financial75.34K-73.55K
Praetorian wealth management20.00K0.01%20.00K
Mariner19.99K-19.99K
Ubs group63.54K-14.80K
Clearstead advisors12.53K0.00%12.53K

Top Sellers

HolderShares% AssetsChange
Goldman sachs group22.64K--137.96K
Blackrock funding, inc. /de291.43K--78.64K
Marshall wace, llp---75.77K
Y-intercept (hong kong)---64.42K
Charles schwab investment management---46.41K

New Positions

HolderShares% AssetsChangeValue
Praetorian wealth management20.00K0.01%20.00K$27.80K
Mariner19.99K-19.99K$27.79K
Clearstead advisors12.53K0.00%12.53K$17.42M
Kestra private wealth services11.00K0.00%11.00K$15.29K
Allworth financial lp12.00-12.00$15.00

Sold Out

HolderChange
True wealth design-3.00
Nisa investment advisors-96.00
Russell investments group-104.00
Sterling capital management-148.00
Wells fargo & company/mn-149.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202518-53.85%1,901,652-26.54%68.38%6-75.00%9-35.71%
Jun 30, 202542-2,793,154-24.36%96.10%2519.05%1614.29%
Mar 31, 20254213.51%3,694,1737.09%129.12%21-32.26%14-
Dec 31, 20243815.15%3,565,51874.27%1225.25%3239.13%--100.00%
Sep 30, 20243332.00%2,045,931465.97%6463.57%234.55%5150.00%

Insider Transactions Trends


DateBuySell
2025 Q2--
2024 Q4--
2024 Q3--

TELO Ownership FAQ


Who Owns Telomir Pharmaceuticals?

Telomir Pharmaceuticals shareholders are primarily institutional investors at 6.34%, followed by 44.98% insiders and 48.68% retail investors. The average institutional ownership in Telomir Pharmaceuticals's industry, Biotech Stocks , is 45.24%, which Telomir Pharmaceuticals falls below.

Who owns the most shares of Telomir Pharmaceuticals?

Telomir Pharmaceuticals’s largest shareholders are Vanguard group (1.1M shares, 3.67%), Blackrock funding, inc. /de (291.43K shares, 0.97%), and Geode capital management (196.03K shares, 0.65%). Together, they hold 5.30% of Telomir Pharmaceuticals’s total shares outstanding.

Does Blackrock own Telomir Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Telomir Pharmaceuticals.

Who is Telomir Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Suncoast equity management is Telomir Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.01% of its assets in 51.19K Telomir Pharmaceuticals shares, valued at 71.16K$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools